Skip to search formSkip to main contentSkip to account menu

Amobarbital

Known as: 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-, 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione, Amobarbital [Chemical/Ingredient] 
A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
Rapid second and fourth derivative ultraviolet spectrophotometric assay procedures are described for the determination of… 
1980
1980
Despite their widespread usage the effect of beta blockers on human performance has been only sparsely studied and results of… 
1978
1978
Twenty-four anxious inpatients were treated with diazepam, amylobarbitone and placebo, each given in flexible dosage for one week… 
1976
1976
Eight normal subjects were tested on a battery of subjective and psychological tests 12 hours after a hypnotic dose of… 
1974
1974
SYSNOPSIS Twenty outpatients suffering from chronic anxiety states completed a trial of anxiolytic drug therapy. They each… 
1973
1973
Graded pressor responses to electrical stimulation of the posterior hypothalamus were accompanied by variable changes in heart… 
1972
1972
A rapid gas-chromatographic method has been developed for the determination of butobarbitone, amylobarbitone, hexabarbitone… 
1971
1971
DRUGS used to induce sleep—the hypnotics—are among the most widely used of all medicaments. It has been estimated that “At a very… 
1966
1966
Whenever one person seeks to influence the behaviour of another, the outcome may be affected by a multiplicity of factors. When… 
1960
1960
The effects of d-amphetamine sulphate, sodium amylobarbitone, and meprobamate were compared with those of a placebo in respect to…